.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Harvard Business School
Mallinckrodt
Chinese Patent Office
Julphar
Dow
Federal Trade Commission
Merck
AstraZeneca

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,872,132

« Back to Dashboard

Summary for Patent: 5,872,132

Title: Form of paroxetine hydrochloride anhydrate
Abstract:"Paroxetine hydrochloride (I) anhydrate ##STR1## free of bound propan-2-ol, and various forms thereof, are useful in the treatment of depression and other disorders for which administration of selective serotonin reuptake inhibitors are indicated."
Inventor(s): Ward; Neal (East Sussex, GB2), Jacewicz; Victor Witold (Kent, GB2)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Application Number:08/733,874
Patent Claim Types:
see list of patent claims
Compound; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,872,132

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9502297Feb 06, 1995
United Kingdom9503112Feb 17, 1995

International Patent Family for Patent: 5,872,132

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO)9600780► Subscribe
Argentina001982► Subscribe
Argentina036856► Subscribe
Austria407528► Subscribe
AustriaA21096► Subscribe
Australia4332896► Subscribe
Australia4786496► Subscribe
Australia701518► Subscribe
Australia740561► Subscribe
Australia9821398► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
Medtronic
Harvard Business School
Queensland Health
Argus Health
Farmers Insurance
Fuji
Cerilliant
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot